Covered recipient · General Payments record
ERIKA SCHWARZ-COHEN
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$2,416.33
- Reported across 53 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,227.35 | 24 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $423.63 | 6 |
| Neurelis, Inc. | $180.77 | 3 |
| SANOFI-AVENTIS U.S. LLC | $127.64 | 1 |
| ABBVIE INC. | $122.19 | 1 |
| Acerta Pharma LLC | $112.70 | 1 |
| Merck Sharp & Dohme Corporation | $67.85 | 3 |
| ALK-Abello, Inc | $60.98 | 3 |
| Corium, Inc. | $42.59 | 2 |
| GlaxoSmithKline, LLC. | $30.33 | 1 |
| Cranial Technologies, Inc | $19.83 | 1 |
| Phadia US Inc. | $19.77 | 1 |
| Astellas Pharma US Inc | $19.07 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (24)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2018201920202023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $122.19 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106045602 | CMS |
| ALK-Abello, Inc | $19.63 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1099895067 | CMS |
| ALK-Abello, Inc | $18.18 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1099895065 | CMS |
| ALK-Abello, Inc | $23.17 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1099895069 | CMS |
| Astellas Pharma US Inc | $19.07 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139280254 | CMS |
| AstraZeneca Pharmaceuticals LP | $112.70 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105785686 | CMS |
| Corium, LLC | $22.46 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100090012 | CMS |
| Corium, LLC | $20.13 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100213039 | CMS |
| Cranial Technologies, Inc | $19.83 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082232024 | CMS |
| GlaxoSmithKline, LLC. | $30.33 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116375996 | CMS |
| Merck Sharp & Dohme LLC | $19.12 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141975668 | CMS |
| Merck Sharp & Dohme LLC | $26.06 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141638176 | CMS |
| Merck Sharp & Dohme LLC | $22.67 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141638174 | CMS |
| Neurelis, Inc. | $36.81 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145653915 | CMS |
| Neurelis, Inc. | $119.79 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145653920 | CMS |
| Neurelis, Inc. | $24.17 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145653924 | CMS |
| Novo Nordisk Inc | $22.64 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097822927 | CMS |
| Novo Nordisk Inc | $125.00 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096603979 | CMS |
| Novo Nordisk Inc | $17.38 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096912526 | CMS |
| Novo Nordisk Inc | $14.30 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097043879 | CMS |
| Novo Nordisk Inc | $125.00 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096581661 | CMS |
| Novo Nordisk Inc | $119.31 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096905265 | CMS |
| Phadia US Inc. | $19.77 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1067578656 | CMS |
| SANOFI-AVENTIS U.S. LLC | $127.64 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139671665 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.